Aziz Mottiwala
Chief Commercial Officer; Director, President and CEO · 4 filings · Latest: Jul 24, 2026
RxSight, Inc.
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Mottiwala Aziz | — | Sep 2, 2026 | Proposed Sale | $81.80 | 8,000 | $654.4K | — | |
TARS | Mottiwala Aziz | — | Sep 1, 2026 | Proposed Sale | $73.96 | 77,698 | $5.7M | — | |
TARS | Mottiwala Aziz | — | Aug 25, 2026 | Proposed Sale | $71.85 | 81,332 | $5.8M | — | |
TARS | Mottiwala Aziz | — | Aug 19, 2026 | Proposed Sale | $72.00 | 53,043 | $3.8M | — | |
TARS | Aziz Mottiwala | Chief Commercial Officer | Mar 19, 2026 | Sale | $67.00 | 4,440 | $297.5K | 61,480 | |
TARS | Aziz Mottiwala | Chief Commercial Officer | Mar 18, 2026 | Sale | $68.71 | 4,330 | $297.5K | 65,920 | |
TARS | Aziz Mottiwala | Chief Commercial Officer | Mar 17, 2026 | Sale | $69.42 | 4,286 | $297.5K | 70,250 | |
TARS | Mottiwala Aziz | — | Mar 19, 2026 | Proposed Sale | $67.00 | 4,440 | $297.5K | — | |
TARS | Mottiwala Aziz | — | Mar 18, 2026 | Proposed Sale | $68.71 | 4,330 | $297.5K | — | |
TARS | Aziz Mottiwala | Chief Commercial Officer | Mar 15, 2026 | Option Exercise | — | 26,482 | — | 74,536 | |
TARS | Mottiwala Aziz | — | Mar 17, 2026 | Proposed Sale | $69.41 | 4,286 | $297.5K | — | |
TARS | Mottiwala Aziz | — | Jun 9, 2025 | Proposed Sale | $44.74 | 17,500 | $783.0K | — | |
TARS | Mottiwala Aziz | — | Mar 20, 2025 | Proposed Sale | $50.11 | 3,365 | $168.6K | — | |
TARS | Mottiwala Aziz | — | Mar 19, 2025 | Proposed Sale | $47.40 | 3,557 | $168.6K | — | |
TARS | Mottiwala Aziz | — | Mar 18, 2025 | Proposed Sale | $46.28 | 3,643 | $168.6K | — |